MOH Quote, Financials, Valuation and Earnings

Centene Corp. has a net margin of -1.41% compared to Molina Healthcare, Inc.'s net margin of -2.21%. Molina Healthcare, Inc.'s return on equity of 10.89% beat Centene Corp.'s return on equity of -27.11%.

Molina Healthcare, Inc. has a consensus price target of $183.00, signalling upside risk potential of 38.93%. On the other hand Centene Corp. has an analysts' consensus of $43.88 which suggests that it could grow by 14.1%. Given that Molina Healthcare, Inc. has higher upside potential than Centene Corp., analysts believe Molina Healthcare, Inc. is more attractive than Centene Corp..

Molina Healthcare, Inc. has a beta of 0.495, which suggesting that the stock is 50.546% less volatile than S&P 500. In comparison Centene Corp. has a beta of 0.483, suggesting its less volatile than the S&P 500 by 51.703%.

Molina Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Centene Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Molina Healthcare, Inc. pays -- of its earnings as a dividend. Centene Corp. pays out -- of its earnings as a dividend.

Molina Healthcare, Inc. quarterly revenues are $11.4B, which are smaller than Centene Corp. quarterly revenues of $49.7B. Molina Healthcare, Inc.'s net income of -$160M is higher than Centene Corp.'s net income of -$1.1B. Notably, Molina Healthcare, Inc.'s price-to-earnings ratio is 15.42x while Centene Corp.'s PE ratio is 8.66x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare, Inc. is 0.15x versus 0.10x for Centene Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Elevance Health, Inc. has a net margin of -1.41% compared to Molina Healthcare, Inc.'s net margin of 1.1%. Molina Healthcare, Inc.'s return on equity of 10.89% beat Elevance Health, Inc.'s return on equity of 13.1%.

Molina Healthcare, Inc. has a consensus price target of $183.00, signalling upside risk potential of 38.93%. On the other hand Elevance Health, Inc. has an analysts' consensus of $389.42 which suggests that it could grow by 14.88%. Given that Molina Healthcare, Inc. has higher upside potential than Elevance Health, Inc., analysts believe Molina Healthcare, Inc. is more attractive than Elevance Health, Inc..

Molina Healthcare, Inc. has a beta of 0.495, which suggesting that the stock is 50.546% less volatile than S&P 500. In comparison Elevance Health, Inc. has a beta of 0.500, suggesting its less volatile than the S&P 500 by 50.02%.

Molina Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Elevance Health, Inc. offers a yield of 2.02% to investors and pays a quarterly dividend of $1.71 per share. Molina Healthcare, Inc. pays -- of its earnings as a dividend. Elevance Health, Inc. pays out 27.13% of its earnings as a dividend. Elevance Health, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Molina Healthcare, Inc. quarterly revenues are $11.4B, which are smaller than Elevance Health, Inc. quarterly revenues of $49.7B. Molina Healthcare, Inc.'s net income of -$160M is lower than Elevance Health, Inc.'s net income of $546M. Notably, Molina Healthcare, Inc.'s price-to-earnings ratio is 15.42x while Elevance Health, Inc.'s PE ratio is 13.50x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare, Inc. is 0.15x versus 0.38x for Elevance Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Oscar Health, Inc. has a net margin of -1.41% compared to Molina Healthcare, Inc.'s net margin of -4.6%. Molina Healthcare, Inc.'s return on equity of 10.89% beat Oscar Health, Inc.'s return on equity of -21.36%.

Molina Healthcare, Inc. has a consensus price target of $183.00, signalling upside risk potential of 38.93%. On the other hand Oscar Health, Inc. has an analysts' consensus of $15.78 which suggests that it could grow by 28.9%. Given that Molina Healthcare, Inc. has higher upside potential than Oscar Health, Inc., analysts believe Molina Healthcare, Inc. is more attractive than Oscar Health, Inc..

Molina Healthcare, Inc. has a beta of 0.495, which suggesting that the stock is 50.546% less volatile than S&P 500. In comparison Oscar Health, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Molina Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Oscar Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Molina Healthcare, Inc. pays -- of its earnings as a dividend. Oscar Health, Inc. pays out -- of its earnings as a dividend.

Molina Healthcare, Inc. quarterly revenues are $11.4B, which are larger than Oscar Health, Inc. quarterly revenues of $3B. Molina Healthcare, Inc.'s net income of -$160M is lower than Oscar Health, Inc.'s net income of -$137.5M. Notably, Molina Healthcare, Inc.'s price-to-earnings ratio is 15.42x while Oscar Health, Inc.'s PE ratio is 51.21x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare, Inc. is 0.15x versus 0.29x for Oscar Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

UnitedHealth Group, Inc. has a net margin of -1.41% compared to Molina Healthcare, Inc.'s net margin of 0.19%. Molina Healthcare, Inc.'s return on equity of 10.89% beat UnitedHealth Group, Inc.'s return on equity of 17.57%.

Molina Healthcare, Inc. has a consensus price target of $183.00, signalling upside risk potential of 38.93%. On the other hand UnitedHealth Group, Inc. has an analysts' consensus of $364.63 which suggests that it could grow by 31.8%. Given that Molina Healthcare, Inc. has higher upside potential than UnitedHealth Group, Inc., analysts believe Molina Healthcare, Inc. is more attractive than UnitedHealth Group, Inc..

Molina Healthcare, Inc. has a beta of 0.495, which suggesting that the stock is 50.546% less volatile than S&P 500. In comparison UnitedHealth Group, Inc. has a beta of 0.409, suggesting its less volatile than the S&P 500 by 59.094%.

Molina Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UnitedHealth Group, Inc. offers a yield of 3.16% to investors and pays a quarterly dividend of $2.21 per share. Molina Healthcare, Inc. pays -- of its earnings as a dividend. UnitedHealth Group, Inc. pays out 65.97% of its earnings as a dividend. UnitedHealth Group, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Molina Healthcare, Inc. quarterly revenues are $11.4B, which are smaller than UnitedHealth Group, Inc. quarterly revenues of $113.2B. Molina Healthcare, Inc.'s net income of -$160M is lower than UnitedHealth Group, Inc.'s net income of $218M. Notably, Molina Healthcare, Inc.'s price-to-earnings ratio is 15.42x while UnitedHealth Group, Inc.'s PE ratio is 20.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare, Inc. is 0.15x versus 0.56x for UnitedHealth Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.